Scientific Officer – Cell Biology (maternity cover) at Institute of Cancer Research

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment. Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top four cancer centres globally. The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.

The Cancer Research UK Cancer Therapeutics Unit, within the Division of Cancer Therapeutics, is a multidisciplinary ‘bench to bedside’ centre, comprising around 160 staff dedicated to the discovery and development of novel therapeutics for the treatment of cancer. The Cancer Therapeutics Unit’s exciting goal is to discover high quality drug candidates for validated biological targets and to progress these candidates to clinical trial. All the scientific disciplines are in place to make this possible. Our biologists work alongside world-class chemists and drug metabolism specialists focusing on new molecular targets emerging from human genome and ground breaking cell biology research. This is an exciting and fast moving area of cancer research, and offers the opportunity to work within a multi-disciplinary environment using state-of-the-art techniques and equipment.

A Scientific Officer position is available immediately in our Target Evaluation and Molecular Therapeutics Team (TEMT) to work on a drug discovery project.  The successful candidate will, under moderate supervision, use contemporary molecular, cellular and biochemical techniques to generate and validate luciferase-based reporter constructs in multiple cancer cell lines.

Applicants should possess a first degree in molecular biology/cell biology/biochemistry or a related subject. Previous experience of basic cell and molecular biology or biochemistry in a work-based laboratory environment is essential.

Salary will be in the range £24,024 to £25,949 pro rata (based on relevance of skills and experience) and the post is offered on a fixed term contract of 6 months, for maternity cover. 

For further information and to apply, please click on the ‘Apply’ button.

We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff.

We value your feedback on the quality of our adverts.
If you have a comment to make about the overall quality of this advert,
or its categorisation then please
send us your feedback